RankAlpha logo
Back to Rankings

ATHE

Alteriry TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ATHE vs peer average
34/100
ATHE vs. peer average (F vs. D)
Grade spread
A 1 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KLRS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $88.18M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKLRSKalaris Therapeutics
ATHE
Alteriry Therapeutics
KLRS
Kalaris Therapeutics
Grade
F
A
Momentum
13
74
Value
41
59
Sentiment
-
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs KLRS

ATHE / KLRS
Grade Position
Below peers
ATHE vs. peer average (F vs. D)
34/100
Momentum
13
KLRS
Value
41
KLRS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ATHE
1
KLRS
Kalaris Therapeutics Inc Common
A
100/100
-4
2
NTHI
NeOnc Technologies Holdings Inc Common
F
20/100
Even
3
SERA
Sera Prognostics Inc Class A Common
F
20/100
Even
4
CGTX
Cognition Therapeutics Inc Common
C
60/100
-2
5
SXTC
China Sxt Pharmaceuticals Inc Class A Common
F
20/100
Even
KLRS is the first peer returned for this comparison set.